1. David, D.S.: Mineral and bone homeostasis in renal failure. Pathophysiology and management. In Calcium Metabolism in Renal Failure and Nephrolithiasis, D.S. David, editor. New York, John Wiley and Sons, 1977, pp. 1–77
2. Voigts, A.L., Felsenfeld, A.J., Llach F.: The effects of calciferol and its metabolites on patients with chronic renal failure. I. Calciferol, dihydrotachysterol and calcifediol. Arch. Intern. Med.143:960, 1983
3. Voigts, A.L., Felsenfeld, A.J., Llach F.: The effects of calciferol and its metabolites on patients with chronic renal failure. II. Calcitriol. 1 alpha hydroxy-vitamin D, and 24, 25 dihydroxyvitamin D3. Arch. Intern. Med.143:1250, 1983
4. Andreoli, S.P., Bergsten, J.M., Sherrard, D.J.: Aluminum intoxication from aluminum-containing phosphate binders in children with azotemia not undergoing dialysis. N. Engl. J. Med.310:1079, 1984
5. Drüeke, T., Lacour, B., Touam, M., Basile, C., Bourdon, R.: Oral aluminum administration to uremic, hyperparathyroid, or vitamin D-supplemented rats. Nephron39:10, 1985